We're sorry. An error has occurred
Please cancel or retry.
A Strategic Myth
Regular price
$25.00
Regular price
$25.00
Sale price
$25.00
Unit price
/
per
Sold out
Re-stocking soon
Jammu and Kashmir has been different things to different people throughout the twentieth century and well into the twenty-first. This book challenges commonly held misconceptions about the region a...
Read More
Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
Couldn't load pickup availability
Ships within 2 business days
-
15 February 2022

Jammu and Kashmir has been different things to different people throughout the twentieth century and well into the twenty-first. This book challenges commonly held misconceptions about the region and brings to light its achievements during the state-led developmental process of Jammu and Kashmir from 1948 to 1988, thus bridging a gap in scholarship concerning this process in the region and the relationship between its political history and social development.
Price: $25.00
Pages: 216
Publisher: Tulika Books
Imprint: Tulika Books
Publication Date:
15 February 2022
Trim Size: 9.50 X 6.25 in
ISBN: 9788194717560
Format: Hardcover
BISACs:
HISTORY / Asia / South / General, HISTORY / Social History, SOCIAL SCIENCE / Regional Studies
Sehar Iqbal has done an excellent job of documenting the unique path of development followed in Jammu and Kashmir and its experience in carrying out a successful land reform programme. I strongly recommend this slim volume to all development scholars and interested readers.
Dr Sehar Iqbal is an independent researcher working at the intersection between research and grassroot development. For her work on reducing infant deaths in the Kashmir valley she received the Women’s Scholarship at the University of Oxford, where she is currently researching solutions for delivering quality education to children of nomadic communities in Jammu and Kashmir. She is a founding Fellow of the India Pakistan Regional Young Leaders Initiative (IPRYLI) administered by the Asia Society, Rockefeller Foundation.